About SimBioSys
SimBioSys is a company based in Chicago (United States) founded in 2016 by Joseph Peterson and John Cole.. SimBioSys has raised $20.25 million across 2 funding rounds from investors including Mayo Clinic, Genoa Ventures and AV8 Ventures. SimBioSys offers products and services including TumorSight Viz, TumorSight RISK, and PhenoScope. SimBioSys operates in a competitive market with competitors including Qure.ai, Subtle Medical, Perspectum, Zebra Medical Vision and Invicro, among others.
- Headquarter Chicago, United States
- Founders Joseph Peterson, John Cole
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Simbiosys Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$20.25 M (USD)
in 2 rounds
-
Latest Funding Round
$5.25 M (USD), Series A
Dec 20, 2024
-
Investors
Mayo Clinic
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SimBioSys
SimBioSys offers a comprehensive portfolio of products and services, including TumorSight Viz, TumorSight RISK, and PhenoScope. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Transforms MRIs into 3D models for cancer preoperative planning.
Estimates cancer recurrence risk using patient data.
Analyzes biomarkers for therapy and dose optimization.
Unlock access to complete
Unlock access to complete
Funding Insights of SimBioSys
SimBioSys has successfully raised a total of $20.25M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.25 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $5.2M
-
First Round
First Round
(26 Oct 2021)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Series A - SimBioSys | Valuation |
investors |
|
| Oct, 2021 | Amount | Series A - SimBioSys | Valuation | Genoa Ventures , Northpond Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SimBioSys
SimBioSys has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Mayo Clinic, Genoa Ventures and AV8 Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage VC firm focused on life science startups
|
Founded Year | Domain | Location | |
|
Early-stage startups are supported by AV8 Ventures through investments.
|
Founded Year | Domain | Location | |
|
Multi-stage tech and life sciences focused venture capital firm investing primarily in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SimBioSys
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SimBioSys
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Simbiosys Comparisons
Competitors of SimBioSys
SimBioSys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Qure.ai, Subtle Medical, Perspectum, Zebra Medical Vision and Invicro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-powered solutions for medical imaging diagnostics
|
|
| domain | founded_year | HQ Location |
AI-driven solutions for medical diagnostic imaging are developed.
|
|
| domain | founded_year | HQ Location |
Precision medicine software for liver disease diagnosis is offered.
|
|
| domain | founded_year | HQ Location |
Provider of AI and SaaS-based medical image based decision support tools
|
|
| domain | founded_year | HQ Location |
Provide contract research imaging services and software
|
|
| domain | founded_year | HQ Location |
SaaS analytics platform for Medical Image Analysis
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Simbiosys
Frequently Asked Questions about SimBioSys
When was SimBioSys founded?
SimBioSys was founded in 2016 and raised its 1st funding round 5 years after it was founded.
Where is SimBioSys located?
SimBioSys is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Who is the current CEO of SimBioSys?
Tushar Pandey is the current CEO of SimBioSys.
Is SimBioSys a funded company?
SimBioSys is a funded company, having raised a total of $20.25M across 2 funding rounds to date. The company's 1st funding round was a Series A of $15M, raised on Oct 26, 2021.
What does SimBioSys do?
SimBioSys was founded in 2016 in Chicago, United States, within the healthcare sector. AI-based decision-making and cancer diagnosis tools are offered to professionals. TumorScope software is utilized, incorporating AI and supercomputing to model cancer behavior from patient MRI, PET, or radiology scans. Pre-treatment predictions for lung, prostate, and breast cancers are generated through these operations.
Who are the top competitors of SimBioSys?
SimBioSys's top competitors include Perspectum, Qure.ai and Subtle Medical.
What products or services does SimBioSys offer?
SimBioSys offers TumorSight Viz, TumorSight RISK, and PhenoScope.
Who are SimBioSys's investors?
SimBioSys has 5 investors. Key investors include Mayo Clinic, Genoa Ventures, AV8 Ventures, Heritage Group, and Northpond Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.